Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ‘superbug’ with a mortality rate that can be upwards of 50% ...
The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...
With antibiotic resistance rising, any novel drugs that are developed are invariably reserved for last-line use when other drugs have failed, meaning the number of patient eligible to get them is ...